70余项中国研究入选2025年ASCO GU大会，邀您畅享全国泌尿肿瘤最新进展（肾癌篇）

肾癌和阴茎癌

口头报告

英文标题：Lenvatinib plus tislelizumab as first-line therapy for advanced fumarate hydratase-deficient renal cell carcinoma：A single-center, single-arm, phase II study.

中文标题：仑伐替尼联合替雷利珠单抗一线治疗晚期富马酸水合酶缺陷型肾细胞癌：一项单中心、单组、II期临床研究

讲者：孔文教授 上海交通大学医学院附属仁济医院

研究壁报

英文标题：Risk factors of complications after inguinal lymph node dissection in patients with penile cancer.

中文标题：阴茎癌患者腹股沟淋巴结清扫术后并发症的危险因素

英文标题：Apatinib monotherapy for pretreated advanced squamous cell carcinoma of the penis：A phase II trial.

中文标题：阿帕替尼单药治疗经治的晚期阴茎鳞状细胞癌：一项II期临床试验

英文标题：Observational study of tislelizumab (Tisle) combined with pazopanib in reducing venous tumor thrombus in clear cell renal cell carcinoma with venous invasion

中文标题：替雷利珠单抗（Tisle）联合培唑帕尼用于减少静脉侵犯的透明细胞肾细胞癌静脉癌栓的观察性研究

英文标题：Clinicopathological features and prognosis of MED15-TFE3 rearrangement renal cell carcinoma：An updated report.

中文标题：MED15-TFE3重排肾细胞癌的临床病理特征和预后：最新报告

英文标题：Safety and efficacy of immune checkpoint inhibitor rechallenge in metastatic fumarate hydratase-deficient renal cell carcinoma：A retrospective study.

中文标题：免疫检查点抑制剂再刺激治疗转移性富马酸水合酶缺陷型肾细胞癌的安全性和有效性：一项回顾性研究

英文标题：Clinicopathological characteristics and prognosis of metastatic non-clear cell renal cell carcinoma.

中文标题：转移性非透明细胞肾细胞癌的临床病理特征及预后

英文标题：Global and regional burden of kidney cancer：Analysis and future predictions based on GBD data from 1990 to 2021.

中文标题：全球及地区肾癌负担：基于1990至2021年GBD数据的分析及未来预测

英文标题：Efficacy and safety of SABR with TKI and IO therapy in patients with mRCC.

中文标题：SABR联合TKI和IO治疗mRCC患者的疗效和安全性

英文标题：Cadonilimab combined with lenvatinib for neoadjuvant therapy in early-stage renal cell carcinoma with indications for partial nephrectomy but high surgical risk：A prospective single-arm phase II clinical trial.

中文标题：卡度尼利单抗联合仑伐替尼用于有肾部分切除术指征但手术风险较高的早期肾细胞癌的新辅助治疗：一项前瞻性单臂Ⅱ期临床试验

英文标题：Efficacy of selective renal tumor embolization combined with axitinib and reduced-dose toripalimab in oligometastatic clear cell renal carcinoma：A comparative analysis with axitinib combined with standard-dose toripalimab.

中文标题：选择性肾肿瘤栓塞联合阿昔替尼及减量特瑞普利单抗治疗寡转移性肾透明细胞癌的疗效：与阿昔替尼联合标准剂量特瑞普利单抗的对照分析

英文标题：Belzutifan monotherapy in Chinese patients (pts) with von Hippel-Lindau (VHL) disease–associated tumors：Results of LITESPARK-015 study.

中文标题：贝组替凡单药治疗中国VHL相关肿瘤患者：LITESPARK-015研究结果

英文标题：Efficacy and safety of fruquintinib combined with serplulimab as 1st line treatment in metastatic or unresectable non-clear cell renal cell carcinoma (nccRCC)：Updated results from a single-arm, multicentre clinical trial.

中文标题：呋喹替尼联合斯鲁利单抗作为转移性或不可切除的非透明细胞肾细胞癌（nccRCC）一线治疗的疗效和安全性：单组多中心临床试验的最新结果

英文标题：Cadonilimab (anti-PD-1 and CTLA-4 bispecific antibody) combined with axitinib for the first-line treatment of advanced or metastatic non-clear renal cell carcinoma：A prospective, single-arm, phase Ib/II study.

中文标题：卡度尼利单抗（抗PD-1和CTLA-4双特异性抗体）联合阿昔替尼用于晚期或转移性非透明性肾细胞癌一线治疗：一项前瞻性、单臂、Ib/II期研究

英文标题：Efficacy of systemic treatments for advanced non-clear cell renal cell carcinoma：A single-arm systematic review and meta-analysis.

中文标题：晚期非透明细胞肾细胞癌全身治疗的疗效：单臂系统评价和荟萃分析

英文标题：The evaluation of therapeutic outcomes of percutaneous US/CT-guided bipolar radiofrequency ablation for small renal masses under local anesthesia.

中文标题：局部麻醉下经皮US/CT引导双极射频消融治疗肾小肿块的治疗效果评估

英文标题：A phase II clinical study of camrelizumab plus apatinib in combination with stereotactic body radiotherapy (SBRT) for advanced non-clear cell renal cell carcinoma (nccRCC).

中文标题：卡瑞利珠单抗联合阿帕替尼和立体定向放射治疗（SBRT）治疗晚期非透明细胞肾细胞癌（nccRCC）的II期临床研究

英文标题：Prognostic value of preoperative fibrinogen in metastatic clear cell renal cell carcinoma patients undergoing cytoreductive nephrectomy：A propensity score-matched study.

中文标题：转移性透明细胞肾细胞癌患者减瘤术前纤维蛋白原的预后价值：倾向评分匹配研究